Clinical Trial on Pharmacokinetics and Tolerability of AP707

Clinical trial NCT05267769 · COMPLETED

Trial details

NCT number: NCT05267769
Sponsor: CannaXan GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Tolerability Safety

Start date: 2022-03-02
Primary completion: 2022-04-03
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.